GlassScriptPhysician profile
Duane E Kreil
NPI 1427013184
$5,367.46
in general payments reported to CMS, 2019-2025
32 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $2,364 · 2021: $520 · 2022: $863 · 2023: $556 · 2024: $497 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.23 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,215.10 | 2019-2020 | |
| Abbvie INC. | $523.69 | 2019-2025 | |
| Myovant Sciences INC. | $490.69 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $331.71 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $282.32 | 2020-2025 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Astellas Pharma US INC | $224.85 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $194.43 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $129.12 | 2021-2025 | |
| Avion Pharmaceuticals | $112.49 | 2019-2023 | Balcoltra |
| Agile Therapeutics, INC. | $89.33 | 2021-2022 | |
| Organon LLC | $77.20 | 2022-2024 | Nexplanon |
| Dysis Medical, INC. | $74.40 | 2021 | |
| Scynexis, INC. | $57.71 | 2022 | |
| Aspira Women'S Health INC | $51.78 | 2019-2022 | |
| Daiichi Sankyo INC. | $50.07 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $46.77 | 2023 | |
| Millicent US INC | $46.66 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Therapeuticsmd, INC. | $33.15 | 2020 | |
| Exeltis, USA INC. | $31.82 | 2020-2022 | |
| Exact Sciences Corporation | $31.82 | 2025 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $30.84 | 2019 | |
| Sage Therapeutics, LLC | $30.66 | 2024 | |
| Mylan Pharmaceuticals INC. | $29.73 | 2021-2022 | |
| Becton, Dickinson and Company | $25.79 | 2023 | Bd Surepath Collection Vial |
| Gynesonics, INC. | $24.81 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $23.24 | 2023 | |
| Evofem Biosciences, INC. | $22.10 | 2021 | |
| Novo Nordisk INC | $20.60 | 2023 | Wegovy |
| Merck Sharp & Dohme LLC | $20.17 | 2025 | Gardasil 9 |
| Kci USA, INC. | $17.50 | 2023 | Prevena, V.A.C.Ulta |
| Meditrina | $13.46 | 2024 | |
| Duchesnay USA Incorporated | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Kreil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.